Bishal Gyawali: 2 most important tables you’ll need for VTE prophylaxis and treatment with DOACs
Bishal Gyawali posted on X about recent paper by him as coauthor, titled “Assessing the benefits and harms of direct oral anticoagulants in patients with cancer for the prophylaxis and treatment of venous thromboembolism: a systematic review and meta-analysis” published on ecancer Medical Science.
Authors: Aakash Desai, Bishal Gyawali
“2 most important tables you’ll need for VTE prophylaxis and treatment with DOACs in patients with cancer.”
Enrique Soto shared Bishal Gyawali’s post adding:
“Agree, excellent tables from a great manuscript published in ecancer medical science!!!”
Source: Bishal Gyawali/X and Enrique Soto/X
Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives. Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.